A detailed history of Schulhoff & CO Inc transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Schulhoff & CO Inc holds 2,600 shares of MEDP stock, worth $877,110. This represents 0.39% of its overall portfolio holdings.

Number of Shares
2,600
Previous 2,330 11.59%
Holding current value
$877,110
Previous $959,000 9.59%
% of portfolio
0.39%
Previous 0.47%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$320.58 - $457.29 $86,556 - $123,468
270 Added 11.59%
2,600 $867,000
Q2 2024

Aug 08, 2024

BUY
$372.0 - $424.34 $1,488 - $1,697
4 Added 0.17%
2,330 $959,000
Q1 2024

May 01, 2024

BUY
$284.87 - $413.31 $21,650 - $31,411
76 Added 3.38%
2,326 $940,000
Q3 2023

Nov 13, 2023

BUY
$233.98 - $281.67 $10,529 - $12,675
45 Added 2.04%
2,250 $544,000
Q2 2023

Aug 01, 2023

BUY
$187.26 - $240.17 $23,407 - $30,021
125 Added 6.01%
2,205 $529,000
Q1 2023

May 05, 2023

BUY
$174.31 - $239.52 $13,073 - $17,964
75 Added 3.74%
2,080 $391,000
Q4 2022

Feb 09, 2023

SELL
$153.06 - $226.57 $153,060 - $226,570
-1,000 Reduced 33.28%
2,005 $425,000
Q3 2022

Nov 08, 2022

SELL
$145.13 - $182.49 $7,256 - $9,124
-50 Reduced 1.64%
3,005 $472,000
Q1 2022

May 09, 2022

BUY
$138.87 - $214.31 $36,106 - $55,720
260 Added 9.3%
3,055 $499,000
Q4 2021

Feb 08, 2022

BUY
$182.74 - $227.9 $4,568 - $5,697
25 Added 0.9%
2,795 $608,000
Q3 2021

Nov 08, 2021

BUY
$170.18 - $198.21 $46,799 - $54,507
275 Added 11.02%
2,770 $524,000
Q2 2021

Aug 03, 2021

BUY
$158.62 - $194.3 $6,344 - $7,772
40 Added 1.63%
2,495 $440,000
Q3 2020

Nov 04, 2020

BUY
$92.95 - $130.61 $2,323 - $3,265
25 Added 1.03%
2,455 $274,000
Q2 2020

Jul 29, 2020

BUY
$68.08 - $95.68 $165,434 - $232,502
2,430 New
2,430 $226,000

Others Institutions Holding MEDP

About Medpace Holdings, Inc.


  • Ticker MEDP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 31,099,900
  • Market Cap $10.5B
  • Description
  • Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...
More about MEDP
Track This Portfolio

Track Schulhoff & CO Inc Portfolio

Follow Schulhoff & CO Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schulhoff & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Schulhoff & CO Inc with notifications on news.